このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Surgical Science Sweden バランスシートの健全性
財務の健全性 基準チェック /66
Surgical Science Swedenの総株主資本はSEK4.6B 、総負債はSEK0.0で、負債比率は0%となります。総資産と総負債はそれぞれSEK5.0BとSEK370.8Mです。 Surgical Science Swedenの EBIT はSEK164.4Mで、利息カバレッジ比率-42.6です。現金および短期投資はSEK659.2Mです。
主要情報
0%
負債資本比率
SEK 0
負債
| インタレスト・カバレッジ・レシオ | -42.6x |
| 現金 | SEK 659.18m |
| エクイティ | SEK 4.59b |
| 負債合計 | SEK 370.80m |
| 総資産 | SEK 4.96b |
財務の健全性に関する最新情報
更新なし
Recent updates
Earnings Beat: Surgical Science Sweden AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 21
Here's Why Surgical Science Sweden (STO:SUS) Has Caught The Eye Of Investors
Apr 16Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Is Still Matching Investor Opinion Despite 25% Slump
Mar 17Results: Surgical Science Sweden AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 24Is There Now An Opportunity In Surgical Science Sweden AB (publ) (STO:SUS)?
Nov 29Should You Be Adding Surgical Science Sweden (STO:SUS) To Your Watchlist Today?
Oct 07Is Surgical Science Sweden AB (publ) (STO:SUS) Trading At A 39% Discount?
Aug 17With EPS Growth And More, Surgical Science Sweden (STO:SUS) Makes An Interesting Case
Jun 20A Look At The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)
May 17Surgical Science Sweden AB (publ) (STO:SUS) Shares Could Be 49% Below Their Intrinsic Value Estimate
Dec 27Is Now The Time To Put Surgical Science Sweden (STO:SUS) On Your Watchlist?
Dec 06Is Now The Time To Look At Buying Surgical Science Sweden AB (publ) (STO:SUS)?
Sep 08We Ran A Stock Scan For Earnings Growth And Surgical Science Sweden (STO:SUS) Passed With Ease
Aug 23Surgical Science Sweden AB (publ) (STO:SUS) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless
May 26Here's Why We Think Surgical Science Sweden (STO:SUS) Is Well Worth Watching
Apr 29An Intrinsic Calculation For Surgical Science Sweden AB (publ) (STO:SUS) Suggests It's 44% Undervalued
Feb 20Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?
Jan 11Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?
Dec 15Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)
Sep 16Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?
Jul 05Calculating The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)
Jun 08Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?
Mar 23Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)
Mar 02Is Surgical Science Sweden AB (publ)'s (STO:SUS) Shareholder Ownership Skewed Towards Insiders?
Feb 09
Surgical Science Sweden AB (publ)'s (STO:SUS) Stock Is Going Strong: Have Financials A Role To Play?
Jan 01What Does Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Indicate?
Dec 14Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?
Nov 26財務状況分析
短期負債: SUSの 短期資産 ( SEK1.0B ) が 短期負債 ( SEK247.7M ) を超えています。
長期負債: SUSの短期資産 ( SEK1.0B ) が 長期負債 ( SEK123.1M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: SUSは負債がありません。
負債の削減: SUS 5 年前には負債がありませんでした。
債務返済能力: SUSには負債がないため、営業キャッシュフロー でカバーする必要はありません。
インタレストカバレッジ: SUSには負債がないため、利息支払い の負担は問題になりません。